Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbinafine Resistance in Tinea Capitis
NCT06400056Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- May 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of Terbinafine in tinea capitis, sponsored by Assiut University. Primary endpoints: Detect the most common Fungal strains that cause tinea capitis and Resistant strain in tinea capitis. Planned start May 2024; status: not yet recruiting.
02
Drugs
Terbinafine
03
Conditions
tinea capitis
Beyond the preview
Go deeper on NCT06400056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06400056.